The HER Pathway & Cancer
Genentech VP of Clinical Oncology Dietmar Berger* discusses the role of the HER2 receptor in metastatic breast cancer.
*While Dietmar was an employee at the time this article was published, he has since left Genentech.
Genentech VP of Clinical Oncology Dietmar Berger* discusses the role of the HER2 receptor in metastatic breast cancer.
*While Dietmar was an employee at the time this article was published, he has since left Genentech.